Gerasimos F.
- Country
- Greece
- Department
- Cardiology department
Research Overview
- A Randomized, Placebo‑Controlled Trial of Zenagamtide (NNC0487‑0111) in Obese Patients with HFpEF or HFmrEF to Reduce CV Death and HF Hospitalization
- Long-term Safety and Tolerability Evaluation of Aficamten (CK-3773274) in Adults with Symptomatic Hypertrophic Cardiomyopathy: An Open-label Extension Study
- Efficacy and Safety of Finerenone in Reducing Morbidity and Mortality in Heart Failure Patients with LVEF ≥40% Hospitalized for Acute Decompensated Heart Failure
Data & Insights
Has run more than one trial at 482 of 1113 partner sites.
Specializations
Ischemic Heart Disease
Research centered on coronary artery pathology and acute coronary events.
- Acute Coronary Syndrome
- Acute Myocardial Infarction
- Stable Ischemic Heart Disease
Efforts target reduction of myocardial injury and improvement of post‑event recovery.
Heart Failure Syndromes
Investigation of chronic cardiac dysfunction across ejection‑fraction spectrums.
- Heart Failure with Reduced Ejection Fraction
- Heart Failure with Preserved Ejection Fraction
- Cardiac Remodeling
Focus includes therapeutic strategies to mitigate progression and hospitalization.
Cardiac Rhythm and Vascular Disorders
Study of arrhythmic conditions and arterial hypertension.
- Atrial Fibrillation
- Hypertension
- Arterial Thromboembolism
Research emphasizes rhythm control and vascular risk mitigation.
Metabolic and Renal Comorbidities
Exploration of metabolic disease interplay with renal function.
- Obesity
- Chronic Kidney Disease
- Diabetes‑Related Cardiovascular Risk
Objectives include integrated management of systemic metabolic stress.
Autoimmune and Systemic Inflammatory Disorders
Investigation of immune‑mediated diseases affecting multiple organ systems.
- Systemic Lupus Erythematosus
- Rheumatoid Arthritis
- Psoriasis
Efforts aim to delineate pathogenic pathways and novel therapeutic targets.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.